When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153
0 विचारों
administrator
07/10/23
Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली